Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Purple Biotech Ltd ADR (NASDAQ: PPBT) closed at $0.6 down -9.24% from its previous closing price of $0.66. In other words, the price has decreased by -$9.24 from its previous closing price. On the day, 1.5 million shares were traded. PPBT stock price reached its highest trading level at $0.6288 during the session, while it also had its lowest trading level at $0.59.
Ratios:
For a deeper understanding of Purple Biotech Ltd ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.88 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PPBT now has a Market Capitalization of 1904885 and an Enterprise Value of 322027136.
Stock Price History:
The Beta on a monthly basis for PPBT is 0.77, which has changed by -0.9267726 over the last 52 weeks, in comparison to a change of 0.18189907 over the same period for the S&P500. Over the past 52 weeks, PPBT has reached a high of $13.95, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is -72.80%, while the 200-Day Moving Average is calculated to be -78.86%.
Shares Statistics:
For the past three months, PPBT has traded an average of 911.61K shares per day and 5297860 over the past ten days. A total of 3.03M shares are outstanding, with a floating share count of 3.03M. Insiders hold about 0.10% of the company’s shares, while institutions hold 1.89% stake in the company. Shares short for PPBT as of 1755216000 were 103149 with a Short Ratio of 0.11, compared to 1752537600 on 132633. Therefore, it implies a Short% of Shares Outstanding of 103149 and a Short% of Float of 4.0.
Earnings Estimates
Currently, 1.0 analysts are dedicated to thoroughly evaluating and rating the performance of Purple Biotech Ltd ADR (PPBT) in the stock market.The consensus estimate for the next quarter is -$0.52, with high estimates of -$0.52 and low estimates of -$0.52.
Analysts are recommending an EPS of between -$1.16 and -$1.16 for the fiscal current year, implying an average EPS of -$1.16. EPS for the following year is -$0.62, with 1.0 analysts recommending between -$0.62 and -$0.62.